BACKGROUND: Within 1 year after percutaneous coronary intervention, more than 20% of patients experience new adverse events. Physical activity confers a 25% reduction in mortality; however, physical activity is widely underused. Thus, there is a need for more powerful behavioral interventions to promote physical activity. Our objective was to motivate patients to achieve an increase in expenditure of 336 kcal/wk or more at 12 months as assessed by the Paffenbarger Physical Activity and Exercise Index. METHODS:Two hundred forty-two patients were recruited immediately after percutaneous coronary intervention between October 2004 and October 2006. Patients were randomized to 1 of 2 groups. The patient education (PE) control group (n = 118) (1) received an educational workbook, (2) received a pedometer, and (3) set a behavioral contract for a physical activity goal. The positive-affect/self-affirmation (PA) intervention group (n = 124) received the 3 PE control components plus (1) a PA workbook chapter, (2) bimonthly induction of PA by telephone, and (3) small mailed gifts. All patients were contacted with standardized bimonthly telephone follow-up for 12 months. RESULTS:Attrition was 4.5%, and 2.1% of patients died. Significantly more patients in the PA intervention group increased expenditure by 336 kcal/wk or more at 12 months, our main outcome, compared with the PE control group (54.9% vs 37.4%, P = .007). The PA intervention patients were 1.7 times more likely to reach the goal of a 336-kcal/wk or more increase by 12 months, controlling for demographic and psychosocial measures. In multivariate analysis, the PA intervention patients had nearly double the improvement in kilocalories per week at 12 months compared with the PE control patients (602 vs 328, P = .03). CONCLUSION: Patients who receive PA intervention after percutaneous coronary intervention are able to achieve a sustained and clinically significant increase in physical activity by 12 months. Trial Registration clinicaltrials.gov Identifier: NCT00248846.
RCT Entities:
BACKGROUND: Within 1 year after percutaneous coronary intervention, more than 20% of patients experience new adverse events. Physical activity confers a 25% reduction in mortality; however, physical activity is widely underused. Thus, there is a need for more powerful behavioral interventions to promote physical activity. Our objective was to motivate patients to achieve an increase in expenditure of 336 kcal/wk or more at 12 months as assessed by the Paffenbarger Physical Activity and Exercise Index. METHODS: Two hundred forty-two patients were recruited immediately after percutaneous coronary intervention between October 2004 and October 2006. Patients were randomized to 1 of 2 groups. The patient education (PE) control group (n = 118) (1) received an educational workbook, (2) received a pedometer, and (3) set a behavioral contract for a physical activity goal. The positive-affect/self-affirmation (PA) intervention group (n = 124) received the 3 PE control components plus (1) a PA workbook chapter, (2) bimonthly induction of PA by telephone, and (3) small mailed gifts. All patients were contacted with standardized bimonthly telephone follow-up for 12 months. RESULTS: Attrition was 4.5%, and 2.1% of patients died. Significantly more patients in the PA intervention group increased expenditure by 336 kcal/wk or more at 12 months, our main outcome, compared with the PE control group (54.9% vs 37.4%, P = .007). The PA intervention patients were 1.7 times more likely to reach the goal of a 336-kcal/wk or more increase by 12 months, controlling for demographic and psychosocial measures. In multivariate analysis, the PA intervention patients had nearly double the improvement in kilocalories per week at 12 months compared with the PE control patients (602 vs 328, P = .03). CONCLUSION:Patients who receive PA intervention after percutaneous coronary intervention are able to achieve a sustained and clinically significant increase in physical activity by 12 months. Trial Registration clinicaltrials.gov Identifier: NCT00248846.
Authors: S C Smith; J T Dove; A K Jacobs; J W Kennedy; D Kereiakes; M J Kern; R E Kuntz; J J Popma; H V Schaff; D O Williams; R J Gibbons; J P Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith Journal: Circulation Date: 2001-06-19 Impact factor: 29.690
Authors: Janey C Peterson; Mary E Charlson; Pamela Williams-Russo; Karl H Krieger; Paul A Pirraglia; Barnett S Meyers; George S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2002 Mar-Apr Impact factor: 4.105
Authors: Rainer Hambrecht; Claudia Walther; Sven Möbius-Winkler; Stephan Gielen; Axel Linke; Katrin Conradi; Sandra Erbs; Regine Kluge; Kai Kendziorra; Osama Sabri; Peter Sick; Gerhard Schuler Journal: Circulation Date: 2004-03-08 Impact factor: 29.690
Authors: Lisa F Berkman; James Blumenthal; Matthew Burg; Robert M Carney; Diane Catellier; Marie J Cowan; Susan M Czajkowski; Robert DeBusk; James Hosking; Allan Jaffe; Peter G Kaufmann; Pamela Mitchell; James Norman; Lynda H Powell; James M Raczynski; Neil Schneiderman Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: R Hambrecht; V Adams; S Erbs; A Linke; N Kränkel; Y Shu; Y Baither; S Gielen; H Thiele; J F Gummert; F W Mohr; G Schuler Journal: Circulation Date: 2003-06-16 Impact factor: 29.690
Authors: Jeff C Huffman; Rachel A Millstein; Carol A Mastromauro; Shannon V Moore; Christopher M Celano; C Andres Bedoya; Laura Suarez; Julia K Boehm; James L Januzzi Journal: J Happiness Stud Date: 2015-10-19
Authors: Christina N Massey; Emily H Feig; Laura Duque-Serrano; Deborah Wexler; Judith Tedlie Moskowitz; Jeff C Huffman Journal: Diabetes Res Clin Pract Date: 2018-11-27 Impact factor: 5.602
Authors: Erin M Bergner; Robin Whittemore; Niral J Patel; Kimberly L Savin; Emily R Hamburger; Sarah S Jaser Journal: Transl Issues Psychol Sci Date: 2018
Authors: Christopher M Celano; Ariana M Albanese; Rachel A Millstein; Carol A Mastromauro; Wei-Jean Chung; Kirsti A Campbell; Sean R Legler; Elyse R Park; Brian C Healy; Linda M Collins; James L Januzzi; Jeff C Huffman Journal: Psychosom Med Date: 2018 Jul/Aug Impact factor: 4.312
Authors: Laura D Kubzansky; Jeff C Huffman; Julia K Boehm; Rosalba Hernandez; Eric S Kim; Hayami K Koga; Emily H Feig; Donald M Lloyd-Jones; Martin E P Seligman; Darwin R Labarthe Journal: J Am Coll Cardiol Date: 2018-09-18 Impact factor: 24.094
Authors: Christina M DuBois; Oriana Vesga Lopez; Eleanor E Beale; Brian C Healy; Julia K Boehm; Jeff C Huffman Journal: Int J Cardiol Date: 2015-05-21 Impact factor: 4.164
Authors: Christopher M Celano; Melanie E Freedman; Eleanor E Beale; Federico Gomez-Bernal; Jeff C Huffman Journal: J Nerv Ment Dis Date: 2018-10 Impact factor: 2.254
Authors: Christopher M Celano; Eleanor E Beale; Shannon V Moore; Deborah J Wexler; Jeff C Huffman Journal: Curr Diab Rep Date: 2013-12 Impact factor: 4.810